As pictured in Fig. 8, our data indicated that long-term application induces resistance to metformin in RCC and this resistance mainly based on the losing sensitivities of AMPK/ AKT and TGF- β/SMAD3 pathways. This evidence concerns the gene PRKAA1 and renal cell carcinoma.